| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |